Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels: Possible mechanism of cardioprotection

Circulation Research

Volumn 81, Issue 6, 1997, Pages 1072-1082

  Garlid, Keith D ^b   Paucek, Petr ^b   Yarov Yarovoy, Vladimir ^b   Murray, Holt N ^a   Darbenzio, Raymond B ^a   D'Alonzo, Albert J ^a   Lodge, Nicholas J ^a   Smith, Mark A ^a   Grover, Gary J ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b NONE

Author keywords

ATP sensitive K+ channel; Heart; Mitochondria; Myocardial ischemia

Indexed keywords

DIAZOXIDE; POTASSIUM CHANNEL; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOPLEGIA; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; ENZYME ACTIVITY; HEART CONDUCTION; HEART PROTECTION; MITOCHONDRIAL MEMBRANE; NONHUMAN; POTASSIUM TRANSPORT; PRIORITY JOURNAL; RAT; SARCOLEMMA;

EID: 0030780773     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.81.6.1072     Document Type: Article

References (36)

1. Edwards G, Weston AH. The pharmacology of ATP-sensitive potassium channels. Annu Rev Pharmacol Toxicol. 1993;33:597-637.
2. Grover GJ. Protective effects of ATP-sensitive potassium channel openers in experimental myocardial ischemia. J Cardiovasc Phamacol. 1994;24(suppl 4):S18-S27.
3. Grover GJ, Newburger J, Sleph PG, Dzwonczyk S, Taylor SC, Ahmed SZ, Atwal KS. Cardioprotective effects of the potassium channel opener cromakalim: stereosclectivity and effects on myocardial adenine nucleotides. J Pharmacol Exp Ther. 1991;257:156-162.
4. McPherson CD, Pierce GN, Cole WC. Ischemic cardioprotection by ATP-sensitive potassium channels involves high-energy phosphate preservation. Am J Physiol. 1993;265:H1809-H1818.
5. ATP channel opener bimakalim on coronary blood flow. monophasic action potential duration, and infarct size in dogs. Circulation. 1994;89:1769-1775.
6. ATP opener cromakalim is not correlated with ischemie myocardial action potential duration. J Cardiorasc Pharmacol. 1955;26:145-152.
7. Grover GJ, D'Alonzo AJ, Hess T, Sleph PG, Darhenzio RB. Glyburide-reversible cardioprotective effect of BMS-180448 is independent of action potential shortening. Cardiovasc Res. 1995;30:731-738.
8. Atwal KS, Grover GJ, Ahmed S, Ferrara FN, Harper TW, Kim KS, Sleph PG, Dzwonczyk S, Russell AD, Moreland S. McCullough JR, Normandin DE. Cardioselective anti-ischemic ATP-sensitive potassium channel openers. J Med Chem. 1993;36:3971-3974.
9. + channel from rat liver and beef heart mitochondria. J Biol Chem. 1992;267:26062-26069.
10. + channel in the mitochondrial inner membrane. Nature. 1991;352:244-247.
11. ATP channel. Biophys J. 1995;68:A145. Abstract.
12. Garlid KD, Paueek P, Yarov-Yarovoy V, Sun X, Schindler PA. The mitochondrial K channel as a receptor for potassium channel openers. J Biol Chem. 1996;271:8796-8799.
13. Faivre J-F, Findlay I. Effects of tolbutamide, glibenclamide and diazoxide upon action potentials recorded from rat ventricular muscle. Biochem Biophys Acta. 1989;984:1-5.
14. McCullough JR, Normandin DE, Conder ML, Sleph PG, Dzwonczyk S, Grover GJ. Specific block of the anti-ischemic actions of cromakalim by sodium 5-hydroxydecanoate. Circ Res. 1991;69:949-958.
15. Lodge NJ, Smith MA. The novel Cardioprotective agent BMS-180448 activates a potassium conductance in cardiac and vascular smooth muscle. Naunyn Schmiedebergs Arch Pharmacol. 1996;354:444-451.
16. Hamill OP, Many A, Neher E. Sakmann B, Sigworth FJ. Improved patch-clamp techniques from high resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981;395:85-100.
17. Matlib MA, Rouslin W, Vaghy PL, Schwartz A. Isolation of cardiac muscle mitochondria. Methods in Pharmacology. New York, NY: Plenum Publishing Corp: 1985;5:25-37.
18. 0 'proton channel' of rat liver mitochondria. J Biol Chem. 1989;264:12029-12036.
19. Garlid KD, Sun X, Paucek P, Woldegiorgis G. Mitochondrial cation transport. Methods Enzymol. 1995;260:331-348.
20. ATP channels from bovine heart sarcolemma, and mitochondria. Biophys J;;1993:64, A311. Abstract.
21. + antiporter. J Biol Chem. 1990;265: 6035-6041.
22. Jones LR. Rapid Preparation of canine cardiac sarcolemmal vesicles by sucrose flotation. Methods Enzymol. 1988;157:85-91.
23. Sargent CA, Smith MA, Dzwonczyk S, Sleph PG, Grover GJ. Effect of potassium channel blockade on the anti-ischemic actions of mechanistically diverse agents. J Pharmacol Exp Ther. 1991;259:97-103.
24. Grover GJ, Dzwonczyk S, Sleph PG. Reduction of ischemic damage in isolated rat hearts by the potassium channel opener RP 52891. Eur J Pharmacol. 1990;191:11-19.
25. + currents activated by metabolic inhibition in rat ventricular myocytes differ from those elicited by the channel opener rimakalim. Pflugers Arch. 1995;429:625-629.
26. Auchampach JA, Grover GJ, Gross GJ. Blockade of ischemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate, Cardiovasc Res. 1992;26:1054-1062.
27. Schulz R, Rose J, Heusch G. Involvement of activation of ATP-dependent potassium channels in ischemic preconditioning in swine. Am J Physiol. 1994;267:H1341-H1352.
28. Toombs CF, Moore TL, Shebuski RJ. Limitation of infarct size in the rabbit by ischemic preconditioning is reversible with glibenclamide. Cardiovasc Res. 1993;27:617-622.
29. + channels in an insulin-secreting cell line. J Membr Biol. 1987;99:215-224.
30. Sturgess NC, Kozlowski RZ, Carrington CA, Hales CN, Ashford MLJ. Effects of sulphonylurcas and diazoxide on insulin secretion and nucleotide-sensitive channels in an insulin-secreting cell line. Br J Pharmacol. 1988;95:83-94.
31. Dunne MJ. Effects of pinacidil, RP 49356 and nicorandil on ATPsensitive potassium channels in insulin-secreting cells. Br J Pharmacol, 1990;99:487-492.
32. Dunne MJ, Aspinall RJ, Petersen OH. The effects of cromakalim on ATP-sensitive potassium channels in insulin-secreting cells. Br J Pharmacol. 1990;99:169-175.
33. + channels from hypertrophied ventricular myocytcs. J Pharmacol Exp Ther. 1992;260:254-260.
34. Rousslin W, Broge C-W. Mechanisms of ATP conservation during ischemia in slow and fast heart rate hearts. Am J Physiol. 1993;264:C209-C216.
35. Monticello TM, Sargent CA, McGill JD, Grover GJ. Amelioration of ischemia/reperfusion injury in isolated rat hearts by the ATP sensitive potassium channel opener BMS-180448. Cardiovasc Res. 1996;31:93-101.
36. Grover GJ, Dzwonczyk S, Monticello T. Comparative effects of cromakalim and diltiazem in ischemic hypertrophied and non-hypertrophied rat hearts. Am J Physiol 1996;271:H174-H182.